# Invesco DB Energy Fund: financial statements, quarterly

DBE · NYSE · CIK 1383062 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbe.md) · [Financials](/companies/dbe/financials.md) · [Filings](/companies/dbe/filings.md) · [Insiders](/companies/dbe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [1.0](/filings/0000950170-24-122589.md) | [1.2 d](/filings/0001193125-26-083548.md) | [1.0](/filings/0000950170-25-067174.md) | [0.9](/filings/0000950170-25-105212.md) | [0.6](/filings/0001193125-25-270336.md) | [0.5 d](/filings/0001193125-26-083548.md) | [0.5](/filings/0001193125-26-209733.md) | [0.4](/filings/0001193125-26-338714.md) | [0.5](/filings/0001193125-25-270336.md) | [0.4 d](/filings/0001193125-26-083548.md) | [0.3](/filings/0001193125-26-209733.md) | [0.7](/filings/0001193125-26-338714.md) |
| Interest expense | $m | [0.0](/filings/0000950170-23-060460.md) | [0.0 d](/filings/0000950170-24-019052.md) | [0.0](/filings/0000950170-24-054958.md) | [0.0](/filings/0000950170-24-092111.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [13.9](/filings/0000950170-24-122589.md) | [(17.4) d](/filings/0001193125-26-083548.md) | [6.7](/filings/0000950170-25-067174.md) | [(0.4)](/filings/0000950170-25-105212.md) | [(6.8)](/filings/0001193125-25-270336.md) | [2.9 d](/filings/0001193125-26-083548.md) | [2.7](/filings/0001193125-26-209733.md) | [(2.7)](/filings/0001193125-26-338714.md) | [0.9](/filings/0001193125-25-270336.md) | [(2.1) d](/filings/0001193125-26-083548.md) | [29.2](/filings/0001193125-26-209733.md) | [(12.3)](/filings/0001193125-26-338714.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001193125-26-083548.md) | not reported | not reported | not reported | not reported | not reported | [2.6](/filings/0001193125-26-338714.md) |
| Total assets | $m | [95.9](/filings/0000950170-23-060460.md) | [74.9](/filings/0000950170-25-027264.md) | [91.4](/filings/0000950170-24-054958.md) | [74.5](/filings/0000950170-24-092111.md) | [50.1](/filings/0000950170-24-122589.md) | [47.3](/filings/0001193125-26-083548.md) | [55.9](/filings/0000950170-25-067174.md) | [52.3](/filings/0000950170-25-105212.md) | [48.4](/filings/0001193125-25-270336.md) | [41.9](/filings/0001193125-26-338714.md) | [88.4](/filings/0001193125-26-209733.md) | [85.3](/filings/0001193125-26-338714.md) |
| Total liabilities | $m | [1.2](/filings/0000950170-23-060460.md) | [1.0](/filings/0000950170-25-027264.md) | [0.1](/filings/0000950170-24-054958.md) | [0.4](/filings/0000950170-24-092111.md) | [0.0](/filings/0000950170-24-122589.md) | [0.0](/filings/0001193125-26-083548.md) | [0.0](/filings/0000950170-25-067174.md) | [0.1](/filings/0000950170-25-105212.md) | [0.0](/filings/0001193125-25-270336.md) | [0.9](/filings/0001193125-26-338714.md) | [3.0](/filings/0001193125-26-209733.md) | [3.2](/filings/0001193125-26-338714.md) |
| Shareholders' equity | $m | [94.6](/filings/0000950170-24-122589.md) | [73.9](/filings/0001193125-26-083548.md) | [91.4](/filings/0000950170-25-105212.md) | [74.1](/filings/0001193125-25-270336.md) | [50.1](/filings/0001193125-25-270336.md) | [47.2](/filings/0001193125-26-338714.md) | [55.8](/filings/0001193125-26-338714.md) | [52.2](/filings/0001193125-26-338714.md) | [48.4](/filings/0001193125-25-270336.md) | [41.0](/filings/0001193125-26-338714.md) | [85.3](/filings/0001193125-26-338714.md) | [82.1](/filings/0001193125-26-338714.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.5) d](/filings/0000950170-24-122589.md) | [2.7 d](/filings/0001193125-26-083548.md) | [(10.1)](/filings/0000950170-25-067174.md) | [16.9 d](/filings/0000950170-25-105212.md) | [17.2 d](/filings/0001193125-25-270336.md) | [6.5 d](/filings/0001193125-26-083548.md) | [(6.6)](/filings/0001193125-26-209733.md) | [0.9 d](/filings/0001193125-26-338714.md) | [4.8 d](/filings/0001193125-25-270336.md) | [4.4 d](/filings/0001193125-26-083548.md) | [(14.3)](/filings/0001193125-26-209733.md) | [(9.0) d](/filings/0001193125-26-338714.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-24-122589.md) | [2.9 d](/filings/0001193125-26-083548.md) | [0.6](/filings/0000950170-25-067174.md) | [0.0 d](/filings/0000950170-25-105212.md) | [0.0 d](/filings/0001193125-25-270336.md) | [3.0 d](/filings/0001193125-26-083548.md) | [0.0](/filings/0000950170-25-067174.md) | [0.0 d](/filings/0000950170-25-105212.md) | [0.0 d](/filings/0001193125-25-270336.md) | [1.6 d](/filings/0001193125-26-083548.md) | not reported | not reported |
| Share repurchases | $m | [3.2 d](/filings/0000950170-24-122589.md) | [40.2 d](/filings/0001193125-26-083548.md) | [4.8](/filings/0000950170-25-067174.md) | [16.9 d](/filings/0000950170-25-105212.md) | [18.2 d](/filings/0001193125-25-270336.md) | [2.8 d](/filings/0001193125-26-083548.md) | [3.8](/filings/0001193125-26-209733.md) | [9.3 d](/filings/0001193125-26-338714.md) | [4.8 d](/filings/0001193125-25-270336.md) | [5.6 d](/filings/0001193125-26-083548.md) | [0.9](/filings/0001193125-26-209733.md) | [20.5 d](/filings/0001193125-26-338714.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 3,150,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338714.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.